Axon: The Growth Is Still There, But the Predictability Premium Is Not
A $1.2 billion drone bet, a deliberate inventory build, and a memory-cost squeeze are forcing investors to re-underwrite Axon at half its old multiple.
AXON · Earnings Call · 2026-11-05
The Market Is Repricing More Than a Quarter
Axon’s Q3 was not a demand miss. Revenue rose 28% to $909 million; software and services grew 43% to $437 million; annual recurring revenue reached $1.8 billion, up 40%; net revenue retention held at 126%. Yet the stock is down 35.6% over the last 90 days and roughly 56% from its August 2025 peak. The market is not arguing with the growth rate. It is arguing with the predictability premium that once came with it. The price-to-revenue multiple has fallen to 14.1x, down 48% from its peak. That is the real story of this report: Axon still grows like a high-performance machine, but it is asking investors to underwrite a lumpier, more capital-intensive machine.
The Drone Bet: From Partner to Strategic Owner
The biggest decision this quarter was the expanded Skydio partnership: an additional $1.2 billion investment, taking Axon’s fully diluted ownership to 37%, plus exclusive public-safety distribution in the U.S. and Canada. It is the largest investment in Axon’s history. Rick Smith did not downplay the ambition:
Flying robots are coming. They aren’t a novelty. They aren’t a someday idea. In the coming decade, we believe there will be millions maybe tens of millions of autonomous drones in American skies.
That is a new strategic axis for Axon—not just body cameras and TASERs, but a drone company strategy built around DFR, counter-drone, 911, Fusus, and the Axon Body 5 as the AI-capable edge device. AI ARR has already passed $100 million. The logic is coherent: a 911 call comes in, a drone arrives first, Fusus builds the picture, and the officer arrives with AI assistance already running.
But the drone strategy is also where the quarter broke. Three large federal D-Drone deployments—about $130 million of revenue and $200 million of bookings—were expected in the second half. One $30 million deployment slipped out of Q3; two more totaling $100 million were removed from Q4 guidance. Josh Isner was blunt:
“we’re taking a very conservative approach... we are not going to force a deployment or bank on timing we don’t fully control” — Joshua Isner, President · 2026-11-05
This is not a total surprise. A year ago, Brittany Bagley warned:
“because of the size of that, you should expect some lumpiness in that segment going forward as counter-drone can win a big deal at one time” — Brittany Bagley, Chief Financial Officer · 2025-08-04
What is new is the scale. Federal bookings are up more than 5x year to date, but procurement is moving slower around funding and election cycles. Rick even tied the ALPR controversy to the political backdrop:
“the political landscape changed a lot in the last 36 hours... We’re going to have a new party in power in Congress” — Rick Smith, Chief Executive Officer & Founder · 2026-11-05
That is the new Congress overhang in one sentence: Axon’s newest growth engines are increasingly exposed to federal timing and legislative noise.
The Inventory Decision: Insurance or Earnings Quality?
The second break is self-inflicted—or, depending on your view, self-insured. Axon deliberately added more than $100 million of inventory in Q3 and cut its full-year free cash flow guide to $350–400 million from $450 million. Management’s rationale is supply-chain risk: geopolitical conflict could disrupt access to batteries and chips by roughly 10–25% depending on the component. And because Axon’s core hardware does not go obsolete—it still sells X2s and Body 3s long past their useful life—the company argues it can carry a year of inventory without writedowns.
“our core hardware does not go obsolete... This makes us different from almost every other connected device company” — Joshua Isner, President · 2026-11-05
That is a genuinely company-unique argument, and it is not boilerplate. But the market is treating it as a free-cash-flow problem, not a strategic option. Free cash flow was negative $145 million in the latest filed quarter, and the balance sheet has shifted: effective net cash swung to negative $634 million. The inventory investment may prove brilliant if supply chains break. Near term, it makes Axon look less like a software compounder and more like a hardware company with a working-capital bet.
Memory and the Margin Tax
The quieter problem is memory. Axon said memory costs are driving about 50 basis points of margin headwind this year, with the impact ramping in Q4 and becoming more than four times larger next year. Management expects elevated memory costs through 2027 and 2028. That is a real tax on the hardware side of the model, and it explains why the Axon Body 5 launch was bifurcated into a standard version and a Pro version—Axon is trying to serve AI-heavy customers without forcing price-sensitive ones to absorb the full cost.
“Memory costs are driving approximately 50 basis points of headwind to margins this year” — Brittany Bagley, Chief Operating Officer & Chief Financial Officer · 2026-11-05
The offset has to come from software mix and operating leverage. Axon’s adjusted gross margin was 59.2% in Q3, and the latest filed gross margin was 60.4%. That is still a strong number, but the direction of travel is no longer purely up. The Memory costs issue is not an Axon-specific demand problem; it is an industry-wide input-cost problem that hits a company selling connected devices at scale. The TASER ION launch and TASER 10 demand help, but they do not fully offset a hardware mix that is getting heavier.
What Would Make the Stock Work Again
The core franchise is not broken. Software and services are approaching half of revenue. Future contracted bookings stand at $15.8 billion. Bookings across newer products—D-Drone, 911, Fusus, and AI—already exceeded $1 billion year to date and could double in Q4. If the delayed federal deals close, the reset guidance may look conservative. If inventory normalizes in early 2027 and memory prices stabilize, free cash flow conversion should recover toward the 60% target.
But the market is now asking a different question: what multiple should a company get when a single drone deployment can swing a quarter and a memory contract can swing a year? A year ago, management said it “really weren't betting on federal for this year... there's probably more upside from federal at this point than there is any risk from it” — Brittany Bagley, Chief Financial Officer · 2025-11-04. Today, federal is material enough to move guidance by nearly 500 basis points of growth. That is the transformation. Axon is no longer just a public-safety SaaS-and-hardware compounder; it is becoming a defense-adjacent autonomy platform with a lumpier revenue curve. The growth is still there. The certainty premium is not.